Show all News

We are working to develop our technology and commercialise MSC-based pharmaceuticals – find out more about our day-to-day work.

More startups participating in the MIT Enterprise Forum Poland accelerator program. The technologies they have to offer are full of surprises!

proseedmag: the MIT Enterprise Forum Poland program aims to speed up the development of recently-established tech companies. It accomplishes this by connecting these innovators with the know-how, experience and assets of leading corporations, investment funds as well as various other organizations from Poland and around the world. Nearly 100 startups have already received a much-needed boost from the accelerator program. Łukasz Owczarek, Head of Acceleration at the Technological Entrepreneurship Foundation which is organizing the program, says that there are still plenty of ground-breaking, youthful companies in Poland – players that absolutely have the potential to conquer foreign markets – provided they receive the right kind of support at the beginning of their journey.
Bioceltix: utilizing the immunomodulatory properties of stem cells in order to treat typical autoimmune conditions in animals. The company creates biopharmaceuticals which offer several advantages versus traditional pharmacology.

Wrote about us

(Un)limited stem cells

biotechnologia.pl: Poland is among the countries where innovative biopharmaceuticals re being designed to treat household animals. Bioceltix is developing MSC-based medicines for dogs, horses and cats. The biopharmaceuticals, which are made in Poland, utilise the anti-inflammatory and ...

Article

More startups participating in the MIT Enterprise Forum Poland accelerator program. The technologies they have to offer are full of surprises!

proseedmag: the MIT Enterprise Forum Poland program aims to speed up the development of recently-established tech companies. It accomplishes this by connecting these innovators with the know-how, experience and assets of leading corporations, investment funds as well as various other ...

Article

Bioceltix is entering an infant industry

All of the stem-cell-based biopharmaceuticals being developed by our company are designed to treat conditions caused by chronic inflammatory diseases. We are developing biopharmaceuticals to treat osteoporosis and atopic dermatitis in dogs, chronic inflammation of the oral cavity as well as ...

Article

We know the results of the 50 Most Creative Minds in Business ranking

The gala that concluded the 8th edition of this ranking took place on June 27th at Warsaw’s Multikino Złote Tarasy. This time the event was conducted in an entirely new format. It was hosted by Grzegorz Kiszluk, Editor-in-Chief of Brief Magazine as well as award winners from previous years. ...

Article

Bioceltix – Wroclaw start-up awarded. Creates biological drugs for animals

Gazeta Wrocławska: Bioceltix develops biological drugs for common pet diseases. At the moment, the company is working on drugs for locomotor system diseases (osteoarthritis), autoimmune diseases (atopic dermatitis) and various types of cancer. – The products that we create use the ...

Article